or Try an Advanced Search...

    Technical Analysis for SCNI - Scinai Immunotherapeutics Ltd.

    Grade Last Price % Change Price Change
    F 3.02 3.07% 0.09
    SCNI closed up 6.55 percent on Wednesday, November 20, 2024, on 49 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Flat
    Historical SCNI trend table...
    Date Alert Name Type % Chg
    Slingshot Bearish Bearish Swing Setup 3.07%
    Bullish Engulfing Bullish 3.07%
    Stochastic Buy Signal Bullish 3.07%
    Lower Bollinger Band Walk Weakness 3.07%
    Wide Bands Range Expansion 3.07%
    Oversold Stochastic Weakness 3.07%
    Narrow Range Bar Range Contraction 9.82%
    Lower Bollinger Band Walk Weakness 9.82%
    Wide Bands Range Expansion 9.82%
    Down 3 Days in a Row Weakness 9.82%
    Older End-of-Day Signals for SCNI ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout 28 minutes ago
    Up 5% 28 minutes ago
    Up 3% 28 minutes ago
    Up 2% 28 minutes ago
    Rose Above Previous Day's High about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SCNI Chart by TradingView
    Basic chart:

    Profile

    Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Disease Contract Manufacturing Organization Autoimmune And Infectious Diseases

    Is SCNI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024
    Sep 16 Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies
    Aug 29 Scinai Immunotherapeutics regains compliance with Nasdaq listing rule
    Aug 29 Scinai Regains Full Compliance with Nasdaq Listing Requirements
    Aug 21 Scinai Announces Closing of Loan Restructuring Agreement with European Investment Bank Converting Approximately $29 million of Debt to Preferred Equity and Leaving Debt Balance of $273,000
    Aug 20 Scinai Immunotherapeutics Ltd. (SCNI) Q2 2024 Earnings Call Transcript
    Aug 20 Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing Shareholder
    Aug 16 Scinai Immunotherapeutics reports H1 results
    Aug 15 Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23
    Jul 23 Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the PEI on the path for Phase 1/2a in Plaque Psoriasis with its anti-IL-17 nanoAb
    See more SCNI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.92
    52 Week Low 2.23
    Average Volume 31,096
    200-Day Moving Average 4.07
    50-Day Moving Average 3.51
    20-Day Moving Average 3.29
    10-Day Moving Average 3.04
    Average True Range 0.25
    RSI (14) 37.11
    ADX 20.38
    +DI 25.00
    -DI 18.51
    Chandelier Exit (Long, 3 ATRs) 3.27
    Chandelier Exit (Short, 3 ATRs) 3.46
    Upper Bollinger Bands 3.89
    Lower Bollinger Band 2.69
    Percent B (%b) 0.2
    BandWidth 36.55
    MACD Line -0.21
    MACD Signal Line -0.16
    MACD Histogram -0.0548
    Fundamentals Value
    Market Cap 12.75 Million
    Num Shares 4.35 Million
    EPS -4.40
    Price-to-Earnings (P/E) Ratio -0.67
    Price-to-Sales 0.00
    Price-to-Book 1.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.26
    Resistance 3 (R3) 3.23 3.09 3.21
    Resistance 2 (R2) 3.09 3.01 3.11 3.19
    Resistance 1 (R1) 3.01 2.95 3.05 3.04 3.17
    Pivot Point 2.87 2.87 2.89 2.89 2.87
    Support 1 (S1) 2.79 2.79 2.83 2.82 2.69
    Support 2 (S2) 2.65 2.73 2.67 2.67
    Support 3 (S3) 2.57 2.65 2.66
    Support 4 (S4) 2.60